» Articles » PMID: 16914725

Functional Interplay Between Histone Demethylase and Deacetylase Enzymes

Overview
Journal Mol Cell Biol
Specialty Cell Biology
Date 2006 Aug 18
PMID 16914725
Citations 119
Authors
Affiliations
Soon will be listed here.
Abstract

Histone deacetylase (HDAC) inhibitors are a promising class of anticancer agents for the treatment of solid and hematological malignancies. The precise mechanism by which HDAC inhibitors mediate their effects on tumor cell growth, differentiation, and/or apoptosis is the subject of intense research. Previously we described a family of multiprotein complexes that contain histone deacetylase 1/2 (HDAC1/2) and the histone demethylase BHC110 (LSD1). Here we show that HDAC inhibitors diminish histone H3 lysine 4 (H3K4) demethylation by BHC110 in vitro. In vivo analysis revealed an increased H3K4 methylation concomitant with inhibition of nucleosomal deacetylation by HDAC inhibitors. Reconstitution of recombinant complexes revealed a functional connection between HDAC1 and BHC110 only when nucleosomal substrates were used. Importantly, while the enzymatic activity of BHC110 is required to achieve optimal deacetylation in vitro, in vivo analysis following ectopic expression of an enzymatically dead mutant of BHC110 (K661A) confirmed the functional cross talk between the demethylase and deacetylase enzymes. Our studies not only reveal an intimate link between the histone demethylase and deacetylase enzymes but also identify histone demethylation as a secondary target of HDAC inhibitors.

Citing Articles

Aberrant DNA methylation as a key modulator of cell death pathways: insights into cancer progression and other diseases.

Zahoor A, Khazer R, Mehraj I, Gani U, Fayaz F, Khanday F Funct Integr Genomics. 2025; 25(1):50.

PMID: 40024973 DOI: 10.1007/s10142-025-01552-x.


Gene Variant Related Neurological and Molecular Biomarkers Predict Psychosis Progression, with Potential for Monitoring and Prevention.

Fryar-Williams S, Tucker G, Clements P, Strobel J Int J Mol Sci. 2025; 25(24.

PMID: 39769114 PMC: 11677369. DOI: 10.3390/ijms252413348.


Epigenetic factors direct synergistic and antagonistic regulation of transposable elements in Arabidopsis.

Hsieh J, Yen M, Hung F, Wu K, Chen P Plant Physiol. 2024; 196(3):1939-1952.

PMID: 39041412 PMC: 11531835. DOI: 10.1093/plphys/kiae392.


Roles of Nuclear Orphan Receptors TR2 and TR4 during Hematopoiesis.

Myers G, Sun Y, Wang Y, Benmhammed H, Cui S Genes (Basel). 2024; 15(5).

PMID: 38790192 PMC: 11121135. DOI: 10.3390/genes15050563.


LSD1 controls a nuclear checkpoint in Wnt/β-Catenin signaling to regulate muscle stem cell self-renewal.

Mouradian S, Cicciarello D, Lacoste N, Risson V, Berretta F, Le Grand F Nucleic Acids Res. 2024; 52(7):3667-3681.

PMID: 38321961 PMC: 11040000. DOI: 10.1093/nar/gkae060.


References
1.
Shi Y, Matson C, Lan F, Iwase S, Baba T, Shi Y . Regulation of LSD1 histone demethylase activity by its associated factors. Mol Cell. 2005; 19(6):857-64. DOI: 10.1016/j.molcel.2005.08.027. View

2.
Utley R, Juan L, Cote J, Adams C, Workman J . In vitro analysis of transcription factor binding to nucleosomes and nucleosome disruption/displacement. Methods Enzymol. 1996; 274:276-91. DOI: 10.1016/s0076-6879(96)74024-7. View

3.
Tsukada Y, Fang J, Erdjument-Bromage H, Warren M, Borchers C, Tempst P . Histone demethylation by a family of JmjC domain-containing proteins. Nature. 2005; 439(7078):811-6. DOI: 10.1038/nature04433. View

4.
Yamane K, Toumazou C, Tsukada Y, Erdjument-Bromage H, Tempst P, Wong J . JHDM2A, a JmjC-containing H3K9 demethylase, facilitates transcription activation by androgen receptor. Cell. 2006; 125(3):483-95. DOI: 10.1016/j.cell.2006.03.027. View

5.
Whetstine J, Nottke A, Lan F, Huarte M, Smolikov S, Chen Z . Reversal of histone lysine trimethylation by the JMJD2 family of histone demethylases. Cell. 2006; 125(3):467-81. DOI: 10.1016/j.cell.2006.03.028. View